Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 107, Issue 8, Pages 1327-1336
Publisher
Springer Nature
Online
2012-09-19
DOI
10.1038/bjc.2012.410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of targeted therapy in ovarian cancer
- (2011) Susana Banerjee et al. EUROPEAN JOURNAL OF CANCER
- Cetuximab in the treatment of patients with colorectal cancer
- (2011) Christopher R Garrett et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer
- (2011) Panagiotis A. Konstantinopoulos et al. PLoS One
- Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro
- (2010) Sarah N. Cross et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer
- (2010) Claire Cole et al. CANCER BIOLOGY & THERAPY
- Epithelial ovarian cancer: Focus on targeted therapy
- (2010) Kyriaki Pliarchopoulou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeted trials in ovarian cancer
- (2010) Jonathan A. Ledermann et al. GYNECOLOGIC ONCOLOGY
- A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier
- (2010) Jai Prakash et al. JOURNAL OF CONTROLLED RELEASE
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Both Germ Line and Somatic Genetics of the p53 Pathway Affect Ovarian Cancer Incidence and Survival
- (2008) F. Bartel et al. CLINICAL CANCER RESEARCH
- Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin
- (2008) Christina Peklak-Scott et al. MOLECULAR CANCER THERAPEUTICS
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now